ESTIMATION OF LIVER IRON CONCENTRATION BY SERUM FERRITIN MEASUREMENT IN NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: ANALYSIS FROM THE 1-YEAR THALASSA STUDY

被引:0
|
作者
Taher, A. [1 ]
Porter, J. [2 ]
Viprakasit, V. [3 ]
Kattamis, A. [4 ]
Chuncharunee, S. [5 ]
Sutcharitchan, P. [6 ,7 ]
Siritanaratkul, N. [3 ]
Galanello, R. [8 ]
Karakas, Z. [9 ]
Lawniczek, T. [10 ]
Habr, D. [11 ]
Ros, J. [10 ]
Zhang, Y. [11 ]
Cappellini, D. [12 ]
机构
[1] Amer Univ Beirut, Beirut, Lebanon
[2] UCL, London, England
[3] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
[4] Univ Athens, Dept Pediat 1, Athens, Greece
[5] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[6] Chulalongkorn Univ, Bangkok, Thailand
[7] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[8] Univ Cagliari, Osped Reg Microcitemie, Cagliari, Italy
[9] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Univ Milan, Ca Granda Fdn IRCCS, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0927
引用
收藏
页码:383 / 383
页数:1
相关论文
共 50 条
  • [31] Measurement of Liver Iron Concentration in a Population of Non-Transfusion Dependent Thalassemia Patients Using a Trained Artificial Neural Network to Analyse Magnetic Resonance Images
    St Pierre, Tim
    Cooper, Tony
    Nguyen Ngoc Trang
    Nguyen Thi Thu Ha
    Dang Thai Ton
    Nguyen Khoi Viet
    Pham Minh Thong
    Nguyen Anh Tri
    Bach Quoc Khanh
    Boulos, Sherif
    House, Michael
    Pang, Wenjie
    Bangma, Sander
    Taher, Ali
    BLOOD, 2017, 130
  • [32] SOF/LDV treatment in patients with transfusion-dependent thalassemia major and HCV genotype 1 or 4 infection: follow-up data on liver stiffness, ferritin and liver iron concentration
    Mangia, Alessandra
    Cenderello, Giovanni
    Piazzolla, Valeria
    Santoro, Rosanna
    Forni, Gianluca
    Antonio, Piga
    HEPATOLOGY, 2017, 66 : 832A - 832A
  • [33] CHRONIC VIRAL-HEPATITIS IN THALASSEMIC LIVER-DISEASE - A LONG-TERM STUDY IN PATIENTS WITH ACUTE HEPATITIS WITH NON-TRANSFUSION-DEPENDENT THALASSEMIA MINOR
    PASTORE, G
    TANNOIA, N
    ANGARANO, G
    MONNO, L
    SANTANTONIO, T
    PIETRAPERTOSA, A
    MALCANGI, G
    PUTIGNANO, A
    SCHIRALDI, O
    VOX SANGUINIS, 1983, 44 (01) : 14 - 24
  • [34] Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
    Gattermann, Norbert
    Finelli, Carlo
    Della Porta, Matteo
    Fenaux, Pierre
    Ganser, Arnold
    Guerci-Bresler, Agnes
    Schmid, Mathias
    Taylor, Kerry
    Vassilieff, Dominique
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Rose, Christian
    LEUKEMIA RESEARCH, 2010, 34 (09) : 1143 - 1150
  • [35] Improvement of Underlying Disease Pathophysiology of Ineffective Erythropoiesis in Non-Transfusion-Dependent (NTD) Patients with β-Thalassemia Receiving Luspatercept: Biomarker Analysis from the BEYOND Trial
    Ugidos Guerrero, Manuel
    Sheth, Sujit
    Hermine, Olivier
    Vodala, Sadanand
    BLOOD, 2023, 142
  • [36] Increased Liver Iron Concentration (LIC) in Adults with Non-Transfusion Dependent Sickle Cell Disease (NTD-SCD): Correlation with Serum Ferritin Concentrations
    Yassin, Mohamed A.
    Soliman, Ashraf Tawfiq
    Desanctis, Vincenzo
    Nashwan, Abdulqadir
    Moustafa, Abbas
    Elomry, Halima
    BLOOD, 2015, 126 (23)
  • [37] Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia
    Ricchi, Paolo
    Meloni, Antonella
    Costantini, Silvia
    Spasiano, Anna
    Di Matola, Tiziana
    Pepe, Alessia
    Cinque, Patrizia
    Filosa, Aldo
    ANNALS OF HEMATOLOGY, 2017, 96 (09) : 1541 - 1546
  • [38] Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia
    Paolo Ricchi
    Antonella Meloni
    Silvia Costantini
    Anna Spasiano
    Tiziana Di Matola
    Alessia Pepe
    Patrizia Cinque
    Aldo Filosa
    Annals of Hematology, 2017, 96 : 1541 - 1546
  • [39] Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al
    Taher, Ali T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (06) : 989 - 990
  • [40] UTILITY OF SERUM FERRITIN LEVELS BETWEEN 300 AND 800 NG/ML IN CLINICAL DECISION MAKING IN NON TRANSFUSION-DEPENDENT THALASSAEMIA WHEN MAGNETIC RESONANCE IMAGING FOR LIVER IRON CONCENTRATION MEASUREMENT IS NOT AVAILABLE
    Saliba, Antoine N.
    Musallam, Khaled M.
    Cappellini, Maria D.
    Viprakasit, Vip
    Daar, Shahina
    Moukhadder, Hassan M.
    Taher, Ali T.
    HAEMATOLOGICA, 2017, 102 : 90 - 91